Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Waters Corp Stock Research

WAT

269.14USD+0.27(+0.10%)Market Closed
Watchlist

Market Summary

USD269.14+0.27
Market Closed
0.10%

WAT Stock Price

WAT RSI Chart

WAT Valuation

Market Cap

15.9B

Price/Earnings (Trailing)

23.54

Price/Sales (Trailing)

5.31

EV/EBITDA

16.48

Price/Free Cashflow

27.77

WAT Price/Sales (Trailing)

WAT Profitability

EBT Margin

27.52%

Return on Equity

114.84%

Return on Assets

20.83%

Free Cashflow Yield

3.6%

WAT Fundamentals

WAT Revenue

Revenue (TTM)

3.0B

Revenue Y/Y

3.68%

Revenue Q/Q

8.16%

WAT Earnings

Earnings (TTM)

674.5M

Earnings Y/Y

-8.68%

Earnings Q/Q

6.83%

Price Action

52 Week Range

248.18353.71
(Low)(High)

Last 7 days

-1.1%

Last 30 days

0.3%

Last 90 days

3.5%

Trailing 12 Months

-4.3%

WAT Financial Health

Current Ratio

2.21

WAT Investor Care

Buy Backs (1Y)

1.93%

Diluted EPS (TTM)

11.34

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for WAT

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-01
Batra Udit
sold (taxes)
-534,219
281
-1,901
president and ceo
2023-08-04
KUEBLER CHRISTOPHER A
sold
-1,165,920
291
-4,000
-
2023-08-04
KUEBLER CHRISTOPHER A
acquired
396,880
99.22
4,000
-
2023-05-12
Chaubal Amol
sold (taxes)
-39,295
271
-145
svp & chief financial officer
2023-05-03
Pratt Jonathan M
sold (taxes)
-11,563
296
-39.00
svp waters division
2023-04-05
Bennett Jianqing
sold (taxes)
-61,742
302
-204
svp ta instruments division
2023-03-27
FEARON RICHARD H
acquired
91,427
302
302
-
2023-03-01
Pratt Jonathan M
sold (taxes)
-265,027
309
-857
svp waters division
2023-03-01
Pratt Jonathan M
acquired
1,050,210
309
3,396
svp waters division
2023-02-28
VERGNANO MARK P
bought
997,927
313
3,185
-

1–10 of 50

Which funds bought or sold WAT recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-12
Farther Finance Advisors, LLC
added
17.86
631
43,979
0.01%
2023-08-24
Alberta Investment Management Corp
unchanged
-
-822,028
5,084,780
0.05%
2023-08-23
WOLVERINE TRADING, LLC
added
117
305,399
655,399
-%
2023-08-23
HEADINVEST, LLC
added
1.4
-347,510
7,399,120
1.59%
2023-08-22
Asset Dedication, LLC
reduced
-0.99
-4,000
26,000
-%
2023-08-22
VIRGINIA RETIREMENT SYSTEMS ET AL
unchanged
-
-3,428,840
21,209,700
0.20%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
reduced
-7.1
-358,000
1,427,000
0.01%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-3.17
-5,047,350
25,278,100
0.04%
2023-08-21
VisionPoint Advisory Group, LLC
new
-
9,595
9,595
-%
2023-08-21
VitalStone Financial, LLC
new
-
28,000
28,000
0.02%

1–10 of 47

Latest Funds Activity

Are funds buying WAT calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own WAT
No. of Funds

Schedule 13G FIlings of Waters

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
fundsmith llp
7.62%
4,524,935
SC 13G
Feb 09, 2023
vanguard group inc
11.45%
6,803,307
SC 13G/A
Jan 27, 2023
bank of new york mellon corp
6.21%
3,689,116
SC 13G/A
Jan 24, 2023
blackrock inc.
11.1%
6,586,957
SC 13G/A
Apr 08, 2022
blackrock inc.
10.1%
6,108,293
SC 13G/A
Feb 11, 2022
fundsmith llp
7.35%
4,510,879
SC 13G
Feb 02, 2022
massachusetts financial services co /ma/
4.2%
2,546,414
SC 13G/A
Feb 01, 2022
blackrock inc.
9.9%
6,069,554
SC 13G/A
Feb 01, 2022
bank of new york mellon corp
6.95%
4,244,893
SC 13G/A
Feb 12, 2021
fundsmith llp
7.10%
4,409,835
SC 13G/A

Recent SEC filings of Waters

View All Filings
Date Filed Form Type Document
Sep 05, 2023
4
Insider Trading
Aug 07, 2023
4
Insider Trading
Aug 04, 2023
144
Notice of Insider Sale Intent
Aug 02, 2023
8-K
Current Report
Aug 02, 2023
10-Q
Quarterly Report
Jul 05, 2023
4
Insider Trading
Jul 05, 2023
4
Insider Trading
Jun 21, 2023
11-K
Employee Benefit Details

Peers (Alternatives to Waters)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
32.2B
7.0B
-6.72% -13.24%
28.38
4.6
5.03% -14.68%
23.9B
4.0B
-5.77% -5.69%
26.91
6.05
2.30% 16.37%
21.1B
4.5B
-18.17% -32.72%
-5.03
4.72
-4.92% -21931.58%
16.1B
2.8B
-15.95% -22.45%
19.74
5.69
-24.31% 21.35%
15.9B
3.0B
0.34% -4.30%
23.54
5.31
3.16% -3.93%
MID-CAP
SMALL-CAP
2.3B
146.1M
-12.37% 57.34%
-7.06
15.43
4.72% -55.19%
938.4M
112.0M
3.91% 175.11%
-14.26
8.38
0.83% 16.42%
749.3M
189.6M
-18.17% -30.00%
-3.92
3.95
18.74% 17.75%
175.9M
114.1M
-2.14% 49.82%
-32.4
1.54
-5.49% -48.58%
112.4M
99.2M
-8.52% -75.83%
-1.98
1.13
-26.56% -199.52%
99.1M
31.5M
-2.61% 47.52%
-0.68
3.14
35.12% -38.47%
71.9M
52.7M
-19.36% -39.22%
-9.51
1.36
2.10% -1984.29%
68.4M
143.9M
-47.25% -90.18%
-0.41
0.48
0.71% -18.99%
62.6M
67.1M
-27.12% -59.81%
-0.57
0.93
-12.13% -17.68%

Waters News

MarketBeat
Gateway Investment Advisers LLC Buys 11412 Shares of Waters Co ....
MarketBeat,
9 hours ago
Defense World
Marketscreener.com

Returns for WAT

Cumulative Returns on WAT

9.8%


10-Year Cumulative Returns

7.9%


7-Year Cumulative Returns

6.4%


5-Year Cumulative Returns

11.4%


3-Year Cumulative Returns

Risks for WAT

What is the probability of a big loss on WAT?

71.2%


Probability that Waters stock will be more than 20% underwater in next one year

11.2%


Probability that Waters stock will be more than 30% underwater in next one year.

0%


Probability that Waters stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does WAT drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Waters was unfortunately bought at previous high price.

Drawdowns

Financials for Waters

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue0.9%2,9922,9662,9722,9502,9012,8682,7862,7362,6712,5092,3652,2952,2782,3582,4072,4052,4062,4032,4202,3922,380
Costs and Expenses1.2%2,1402,1142,0992,1012,0512,0221,9641,9131,8811,7601,7201,6771,6451,7021,6981,6891,6911,6871,6801,6661,667
  S&GA Expenses3.7%708683658657645641627607590549554542532548535536537541537542551
  R&D Expenses1.0%180178176171170171168165158144141138138143143144145144143140139
EBITDA-100.0%-943959934932937923928894773660630645670727------
EBITDA Margin-100.0%-0.32*0.32*0.32*0.32*0.33*0.33*0.34*0.33*0.31*0.28*0.27*0.28*0.28*0.30*------
Interest Expenses22.7%64.0052.0049.0046.0044.0045.0045.0045.0045.0046.0049.0052.0053.0051.0049.0046.0046.0046.0049.0052.0056.00
Earnings Before Taxes-1.5%804816838815814819806811779727611578592619678652656659682710695
EBT Margin-100.0%-0.28*0.28*0.28*0.28*0.29*0.29*0.30*0.29*0.29*0.26*0.25*0.26*0.26*0.28*------
Net Income-2.1%67568970869770270569369566061652250451553759257758059159455.0051.00
Net Income Margin-100.0%-0.23*0.24*0.24*0.24*0.25*0.25*0.25*0.25*0.25*0.22*0.22*0.23*0.23*0.25*------
Free Cashflow-100.0%-610612631641727747797802857791715691619643------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets37.5%4,5483,3073,2813,0703,0413,0413,0953,1163,1043,2122,8402,6792,6482,6672,5572,5612,8233,2503,7274,0434,158
  Current Assets-5.2%1,6811,7741,7641,5761,5641,5851,6291,6581,6391,7681,4011,2921,2691,3281,3121,3441,6202,0782,6632,9713,124
    Cash Equivalents-32.2%330486481444419480501525460684437375339390336405588685796689742
  Inventory7.5%537499456442410382356389349328304327344344321369352333292314300
  Net PPE4.2%615590582547546547548530527514494470459439417381369356343338336
  Goodwill201.2%1,30043243042042843643843744043844443142742472.00354356357356358358
Liabilities39.5%3,7772,7072,7772,6852,6482,6662,7272,8212,8352,9812,6082,7212,8403,0052,7732,4462,2672,2822,1602,1672,183
  Current Liabilities0.9%809802786732747688681672681785805722697551591597612603449448475
    LT Debt, Non Current80.4%2,5801,4301,5251,4951,4341,4441,5141,6141,6031,6031,2071,4211,5461,8461,5811,2561,0481,0481,1481,1481,148
Shareholder's Equity28.6%771600504385392375368295268231232----1165569681,5671,8761,975
  Retained Earnings1.7%8,8008,6508,5098,2828,1267,9617,8017,5857,4237,2567,1086,8906,7636,6406,5876,3876,2496,1045,9955,8105,669
  Additional Paid-In Capital0.8%2,2322,2152,2002,1822,1662,1382,1152,1062,0902,0542,0291,9831,9591,9481,9271,8981,8841,8721,8351,8151,799
Shares Outstanding0.0%59.0059.0059.0060.0060.0061.0061.0061.0062.0062.0062.0062.0062.0062.0063.0066.0069.0072.0073.0077.0078.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations-6.4%572610612631641727747797802857791715691619643633631604604615623
  Share Based Compensation2.6%46.0044.0043.0039.0035.0033.0030.0031.0034.0036.0037.0037.0037.0038.0039.0038.0038.0038.0038.0038.0041.00
Cashflow From Investing-809.4%-1,467-161-107-28.9842.00-53.63-231-285-352-292-264-283-2082057691,2511,2621,2221,6831,126964
Cashflow From Financing281.1%800-441-509-652-700-854-438-356-329-284-440-479-737-1,116-1,872-2,154-2,044-1,836-2,119-1,650-1,411
  Buy Backs-28.8%3745256266336296466494933421731967561,3361,9122,4692,4082,0921,7861,315903720

WAT Income Statement

2023-07-01
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Jul. 01, 2023
Jul. 02, 2022
Jul. 01, 2023
Jul. 02, 2022
Revenues:    
Total net sales$ 740,576$ 714,319$ 1,425,250$ 1,404,891
Costs and operating expenses:    
Selling and administrative expenses186,953161,877368,909319,352
Research and development expenses45,87344,00688,56484,478
Purchased intangibles amortization6,8151,5988,2943,271
Acquired in-process research and development  09,797
Total costs and operating expenses540,717514,6871,051,2231,009,789
Operating income199,859199,632374,027395,102
Other (expense) income, net(352)1,5351,0361,705
Interest expense(23,272)(11,419)(37,716)(22,478)
Interest income4,0402,5268,1014,640
Income before income taxes180,275192,274345,448378,969
Provision for income taxes29,72127,41053,97154,274
Net income$ 150,554$ 164,864$ 291,477$ 324,695
Net income per basic common share$ 2.56$ 2.74$ 4.97$ 5.38
Weighted-average number of basic common shares58,85760,20658,70360,399
Net income per diluted common share$ 2.55$ 2.72$ 4.95$ 5.35
Weighted-average number of diluted common shares and equivalents59,01060,51058,90960,744
Product [Member]    
Revenues:    
Total net sales$ 477,926$ 469,630$ 914,383$ 920,470
Costs and operating expenses:    
Costs and operating expenses194,354202,356374,708393,966
Service [Member]    
Revenues:    
Total net sales262,650244,689510,867484,421
Costs and operating expenses:    
Costs and operating expenses$ 106,722$ 104,850$ 210,748$ 198,925

WAT Balance Sheet

2023-07-01
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jul. 01, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 329,693$ 480,529
Investments885862
Accounts receivable, net693,436722,892
Inventories536,828455,710
Other current assets120,342103,910
Total current assets1,681,1841,763,903
Property, plant and equipment, net615,211582,217
Intangible assets, net649,731227,399
Goodwill1,313,501430,328
Operating lease assets92,41286,506
Other assets196,157191,100
Total assets4,548,1963,281,453
Current liabilities:  
Notes payable and debt50,00050,000
Accounts payable81,91893,302
Accrued employee compensation35,522103,300
Deferred revenue and customer advances324,665227,908
Current operating lease liabilities25,90826,429
Accrued income taxes121,294132,545
Accrued warranty12,40911,949
Other current liabilities157,671140,304
Total current liabilities809,387785,737
Long-term liabilities:  
Long-term debt2,580,1981,524,878
Long-term portion of retirement benefits43,56538,203
Long-term income tax liabilities154,376248,496
Long-term operating lease liabilities66,85662,108
Other long-term liabilities122,585117,543
Total long-term liabilities2,967,5801,991,228
Total liabilities3,776,9672,776,965
Commitments and contingencies (Notes 7, 8 and 9)
Stockholders' equity:  
Preferred stock, par value $0.01 per share, 5,000 shares authorized, none issued at July 1, 2023 and December 31, 202200
Common stock, par value $0.01 per share, 400,000 shares authorized, 162,576 and 162,425 shares issued, 59,046 and 59,104 shares outstanding at July 1, 2023 and December 31, 2022, respectively1,6261,624
Additional paid-in capital2,232,0552,199,824
Retained earnings8,800,0648,508,587
Treasury stock, at cost, 103,530 and 103,321 shares at July 1, 2023 and December 31, 2022, respectively(10,133,716)(10,063,975)
Accumulated other comprehensive loss(128,800)(141,572)
Total stockholders' equity771,229504,488
Total liabilities and stockholders' equity$ 4,548,196$ 3,281,453
Udit Batra
7800
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.